Apotex Recalls One Lot of Generic Ozempic Pens Over Incorrect Dose Display
Health Canada says pens from lot 7000636A of Apo-Semaglutide may show and deliver 0.25 mg or 0.5 mg instead of the 1 mg dose. One lot is affected. Here is how to check yours.
Check your lot number
Affected: Apo-Semaglutide 1 mg-dose pen (4 mg/pen), DIN 02568012, lot 7000636A. Do not stop your medication on your own. Talk to your pharmacist or prescriber first.
What Was Recalled
On September 23, 2026, Apotex recalled one lot of its generic Ozempic pen, Apo-Semaglutide. Health Canada's notice says pens from lot 7000636A may display a 0.25 mg or 0.5 mg dose in the dose window and deliver that dose instead of the expected 1 mg.
- Product: Apo-Semaglutide injection, 1 mg-dose pen (4 mg/pen), 1.34 mg/mL solution, DIN 02568012
- Lot: 7000636A
- Recall date: September 23, 2026. Health Canada reference RA-82679, Type II, recall depth: retailers
- Distribution: Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Ontario and Quebec
How to Check Your Pen
The lot number is printed on the pen and on its box. If it reads 7000636A, your pen is in the recall. If it reads anything else, this notice does not apply to it.
Because this is a retailer-level recall, the notice is aimed at pharmacies first. If your generic semaglutide arrives by mail from an online program, you may not hear about it unless you check. Apo-Semaglutide is the Apotex generic that our earlier reporting on the generic price dropcovered. We have not seen a statement on whether this lot reached any program's patients, so we are not saying that it did.
What to Do
- Read the lot number. If it is not 7000636A, no action is needed under this recall.
- If it is 7000636A, speak to your pharmacist or prescriber before stopping or changing your medication, and about how to replace the pen.
- Questions about the recall go to Apotex. Report side effects, or any other product safety complaint, to Health Canada.
The notice concerns one generic lot only. It does not name brand-name Ozempic, Wegovy, or other GLP-1 medication, and it is not a finding about generic semaglutide as a whole. Our generic semaglutide guide covers how the generics compare on price and availability.
If You Would Rather Use a Brand-Name Pen
A recall like this leads some people to ask about brand-name medication instead. That is a conversation for you and a licensed clinician, and brand-name usually costs more per month than generic, as our cost guide sets out. If you want to explore it, Felix Health offers online weight loss programs with brand-name medication (Ozempic, Wegovy, Mounjaro) and Canadian-licensed practitioners. Our best Ozempic providers ranking compares the options.
Brand-name option: Felix Health
Advertising disclosure: Felix Health is an affiliate partner and we may earn a referral fee if you sign up through this link. It does not change how we report the news or how we rank providers. See our disclosures.
See Felix Health brand-name options →Sponsored link. Felix serves AB, BC, MB, NB, NL, NS, ON, PE and SK, not Quebec or the territories. A licensed clinician decides independently whether any prescription is right for you.
Sources
Health Canada, Recalls and Safety Alerts: Apo-Semaglutide Injection: Incorrect dose display (RA-82679; recall date September 23, 2026; original publication September 25, 2026). Accessed September 29, 2026.